The Food and Drug Administration has warned Illinois pharmaceutical company Abbott Laboratories over manufacturing violations at its pharmaceutical plant in Illinois. A letter posted on the FDA’s website states that Abbott distributed some parts of devices after the company become aware of circuit flaws. The FDA did not name the devices in question. The FDA said that it wants Abbott to notify the agency within 15 days of August 12 of how it plans to prevent the problems in the future.
To read more about the FDA warning.